A small drug company said it won approval Friday from the Food and Drug Administration to market the first drug meant to undo the effects of local dental anesthesia.

A program in Alaska trains dental therapists to provide basic services, such as drilling and filling cavities, often at a lower cost and in communities chronically underserved.